Perspectives on Achieving Institutional Trust in Personalized Medicine

Perspectives of personalized medicine in traditional persian medicine

The approach of personalized medicine has received a great deal of attention over the last century, emphasizing attention to the patient rather than the disease. Personalized medicine tries to plan the patient's condition and treatment method by considering the culture, personal preferences and experiences and health beliefs of the person as well as the values and lifestyle of the person, and e...

Policy perspectives on the emerging pathways of personalized medicine

Remarkable advances in the fundamental knowledge about the biological basis of disease and technical advances in methods to assess genomic information have led the health care system to the threshold of personalized medicine. It is now feasible to consider strategic application of genomic information to guide patient management by being predictive, preemptive, and preventive, and enabling patie...

Evolving institutions of trust: personalized and institutional bases of trust in Nigerian and Ghanaian food trading

Personalized medicine in oncology. New perspectives in management of gliomas

Studies on genetic and epigenetic mechanisms of carcinogenesis have led to the discovery of crucial genetic events for many of particular malignancies. This was followed by invention of new therapeutic approaches based on molecular mechanisms underlying cancer development and progression that bears the name of personalised medicine. In the case of gliomas, ascertainment of genetic/epigenetic ma...

Integrating Patient Perspectives into Personalized Medicine in Idiopathic Pulmonary Fibrosis

Idiopathic pulmonary fibrosis (IPF) is a progressive and ultimately fatal disease which has a major impact on patients' quality of life (QOL). Except for lung transplantation, there is no curative treatment option. Fortunately, two disease-modifying drugs that slow down disease decline were recently approved. Though this is a major step forward, these drugs do not halt or reverse the disease, n...